Showing 301-310 of 10387 results for "".
5 Ways to Improve the Patient Experience Through Internal Marketing
https://practicaldermatology.com/topics/practice-management/5-ways-to-improve-the-patient-experience-through-internal-marketing/23631/Getting a patient in the door is the first step. Here’s how to build lasting relationships and grow referrals.Mycosis Fungoides: Practical Tips on Specific Therapies
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-practical-tips-on-specific-therapies/21973/With common sense and knowledge of the therapy being administered, the dermatologist can effectively and safely treat MF patients.Journal Club: Combining Dupilumab and Omalizumab
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combining-dupilumab-and-omalizumab/37872/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, and editorial board member Brad Glick, DO, MPH, FAAD, discuss a recent article about combination therapy with dupilumab and omalizumab for atopic dermatitis. Silva IC, Daher R, Khattri S. Combined use of Omalizumab and dupilumabLupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.Comorbidities in Hidradenitis Suppurativa
https://practicaldermatology.com/issues/march-2025/comorbidities-in-hidradenitis-suppurativa/33164/Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterized by inflamed abscesses, nodules forming tunnels that can lead to scarring in intertriginous areas.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.Mineral Sunscreens with Iron Oxides are Underused for Dyschromia in Skin of Color
https://practicaldermatology.com/topics/skin-of-color/mineral-sunscreens-with-iron-oxides-are-underused-for-dyschromia-in-skin-of-color/23697/A local survey highlights the opportunity for dermatologists to counsel and educate skin of color patients on the use of tinted mineral sunscreens for bothersome dyschromia.Choosing or Evaluating Your Advisors: 3 Mistakes to Avoid
https://practicaldermatology.com/issues/august-2025/choosing-or-evaluating-your-advisors-3-mistakes-to-avoid/36707/If the recent inflationary economy, high interest rates, and market volatility have caused you to adopt a new or renewed focus on financial matters, you are not alone. Perhaps you are planning to seek help from a professional advisor for the first time, considering changing or re-evaluating your cur